A NOVEL COMBINED TOPICAL AGENT FOR THE TREATMENT OF CHRONIC VULVOVAGINITIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The efficiency and safety of treatment for chronic vulvovaginal infection with a novel topical agent containing metronidazole and miconazole (Metromicon-Neo® vaginal suppositories, Aveksima, Russia) were evaluated by analyzing different clinical and laboratory parameters and susceptibility to antimicrobial drugs and by assessing quality of life in patients through with the SF-26 questionnaire.

Full Text

Restricted Access

About the authors

I. Sarvilina

«Novomeditsina» Medical Center

Email: isarvilina@mail.ru
Rostov-on-Don

N. Kuzmina

«Skandinavia» Clinic

Email: isarvilina@mail.ru
Saint Petersburg

References

  1. Малова И.О., Скворцова Р.Г., Кузьмина Н.И. Клинико-микробиологи- ческая характеристика вульвовагинитов у девочек // Вестн. дерматол. и вене- рол. - 1998; 1: 27-31
  2. Меньшикова Н.С. Петрова М.С. Петров И.А. Современное лечение неспецифического вульвовагинита // Сибирский мед. жур. - 2010. - Т. 25; 4-2; 125-127
  3. Прилепская В.Н. Клиника, диагностика и лечение вульвовагинального кандидоза (клиническая лекция) // Гинекология. - 2001; 3 (6): 201-5
  4. Яковлев В.П., Яковлев С.В. и др. Рациональная антимикробная фар- макотерапия: Рук. для практикующих врачей. Под общ. ред. В.П. Яковлева, С.В. Яковлева / М.: Литтера, 2003; 1008 с
  5. Foxman, B., Muraglia, R., Dietz, J. et al. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey // J. Low Genit. Tract. Dis. - 2013; 17 (3): 340-5
  6. Schmid G. Trichomoniasis treatment in women: RHL commentary (last revised: 28 July 2003). The WHO Reproductive Health Library; Geneva: World Health Organization

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies